Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-11-10

Clinical Trial Update: Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology [NA]

View source ↗

Summary

A completed clinical trial evaluating directional deep brain stimulation technology for dystonia in Parkinson's disease patients; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Dystonia-Parkinsonism, Adult-Onset, Parkinson Disease | NA | Status: COMPLETED | Results posted: 2022-11-10